Industries / Biotech & Life Sciences
Catch biotechs when clinical milestones trigger scale-up.
Biotech infrastructure buying follows a predictable pattern: trial success, funding, facility buildout. We find companies at the moment they need to scale - not after they have picked vendors.
Triggers we track for biotech
Clinical trial milestones
Phase 2 and Phase 3 success triggers scale-up roadmaps. Companies need to build manufacturing capacity fast.
Example signal
Positive Phase 2 results announced - accelerating manufacturing scale-up plans.
Facility expansions
New GMP facilities need validated equipment, software, and services. Multi-site buildouts mean standardization.
Example signal
Expanding from 1 to 3 manufacturing facilities - hiring 12 roles across sites.
Series funding rounds
Post-funding biotech companies have budget and pressure to scale. Infrastructure decisions happen fast.
Example signal
$45M Series C to fund manufacturing scale-up and commercial readiness.
Leadership from big pharma
VPs and Directors from Moderna, Pfizer, and other majors know enterprise procurement. They move fast.
Example signal
VP Operations hired from Moderna to lead manufacturing expansion.
Results for life sciences vendors
6x
higher LTV vs cold outreach
55%
of leads in active buying cycles
Multi-year
contracts from first engagement
See biotech leads in scale-up mode
We will research 2-3 companies in your target market so you can see the milestone signals before committing.